Viome (Full Body Intelligence)

Overview

Viome (Full Body Intelligence) is the multi-omic microbiome + cellular + bio-age specialist — manufactured by Viome (founded 2016 in Bellevue WA), with structural value claim fundamentally different from epigenetic-clock alternatives (TruDiagnostic, Elysium, NOVOS, Generation Lab): Viome combines gut microbiome + oral microbiome + cellular health analysis with biological age in single multi-sample test (stool + blood + saliva). The structural differentiator is metatranscriptomic technology — measures microbial gene expression, not just microbial presence — unique in DTC consumer space.

The structural value claim is genuine for users wanting multi-omic comprehensive health view: 60+ health scores including biological age, gut health, mitochondrial health, immune stress, and personalized food recommendations (superfoods + foods to avoid). HSA / FSA eligibility provides effective-cost reduction. For users prioritizing microbiome-driven personalized nutrition + bio-age as one component of broader health snapshot, Viome is structurally distinctive.

The structural editorial caveats are significant and operational: Trustpilot 2.4/5 from 1,300+ reviews is the lowest aggregate score in the entire bio-age testing category by wide margin — meaningfully below Sleep Number’s 1.6 and other low-scored brands we’ve reviewed. Common complaint patterns include supplement-pressure (Viome aggressively cross-sells custom supplement formulations at $150/mo), customer service responsiveness issues, and total cost reaching $2,000+/year when supplements are included. The bio-age methodology is microbiome-based, not epigenetic — less validated for true biological aging vs DNA methylation clocks. Biological age is one of 60+ scores rather than primary focus.

For users matched to multi-omic microbiome-driven health-tracking positioning willing to absorb the documented operational concerns and methodological caveats, Viome is structurally distinctive. For users wanting validated epigenetic bio-age methodology, strong consumer-experience signal, or cost-priority positioning, alternatives are structurally better matched.

The 2.4 Trustpilot Concern

This is the central editorial concern. Viome’s 2.4 Trustpilot from 1,300+ reviews represents the worst consumer-experience signal in the bio-age testing category we’ve reviewed:

• TruDiagnostic: 4/5 from 200 reviews
• Elysium: not published (limited public Trustpilot)
• GlycanAge: 4/5 from 100 reviews
• Tally Health: 3.6/5 from 36 reviews
• InsideTracker: 4.1/5 from 290 reviews
• Viome: 2.4/5 from 1,300+ reviews

The combination of large review base + low aggregate score reflects systemic operational issues rather than isolated incidents. Common complaint patterns:

• Supplement-pressure (aggressive $150/mo supplement upsells)
• Customer service non-responsiveness
• Subscription / billing complaints
• Total-cost-vs-results expectations gap

For buyers, the Trustpilot signal is a structural concern that should weight heavily in evaluation.

When Viome Makes Sense

Strong fit: Multi-omic comprehensive health-tracking enthusiasts; gut-microbiome-focused users; users wanting microbiome + cellular + bio-age in single test; HSA / FSA-funded buyers; users disciplined enough to ignore aggressive supplement upsells.

Weaker fit: Validated epigenetic bio-age methodology preference (TruDiagnostic, NOVOS, Generation Lab); strong consumer-experience signal preference (any other major bio-age brand); cost-priority buyers (Viome supplements push total cost past $2K/year); users averse to supplement-pressure cross-selling.

3-Year Cost of Ownership

Compare: TruDiagnostic ($1,197-2,397 / 3 yr), NOVOS Age ($350-1,050), Tally Health ($229-700), MyDNAge ($299-900), Elysium Index ($299-900), Generation Lab ($1,470-1,500), GlycanAge ($350-1,050).

Verdict: Conditional

Viome (Full Body Intelligence) earns a conditional verdict on the strength of its category-unique multi-omic positioning combining gut microbiome + oral microbiome + cellular health with biological age in single test, metatranscriptomic technology unique in DTC space, 60+ health scores comprehensive view, personalized food recommendations, and HSA / FSA eligibility — balanced against Trustpilot 2.4/5 from 1,300+ reviews (lowest aggregate in bio-age category by wide margin), bio-age positioned as one of 60+ scores rather than primary focus, total-cost-with-supplements reaching $2,000+/year, microbiome-based bio-age methodology less validated than epigenetic clocks, and documented customer service + supplement-pressure complaints across consumer reports.

For multi-omic microbiome-driven health-tracking enthusiasts willing to absorb documented operational concerns and aggressive supplement cross-selling, Viome is structurally distinctive. For users wanting validated epigenetic bio-age methodology, strong consumer-experience signal, or cost-priority positioning, structurally better-matched alternatives exist (TruDiagnostic for premium epigenetic, NOVOS Age for value epigenetic, Tally Health for accessible-entry, MyDNAge for Horvath-Clock methodology).

The editorial framing: Viome’s 2.4 Trustpilot from 1,300+ reviews is structurally concerning enough to weight heavily in any purchase decision. The methodology + multi-omic positioning may be genuinely interesting; the operational execution per documented user reports is among the worst in our review database.

Changelog

• 2026-05-07: Initial review published based on Viome (Full Body Intelligence) published specifications, multi-omic methodology positioning, Trustpilot 2.4/5 from 1,300+ reviews aggregation, total-cost analysis, and aggregated user-report data.